Contineum Therapeutics’ CSO Trims Stake in Quiet Move Amid Stock Surge
Contineum Therapeutics insider sale: Lorrain Daniel S. sells 4,170 shares at $14.82. Understand why it’s routine, not a red flag, and what it means for investors.
3 minutes to read